I

Immunitas Therapeutics

42 employees

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Therapeutics

Life Science

Date founded

2019

Funding rounds raised

Total raised

$58M

from 8 investors over 8 rounds

I

Immunitas Therapeutics raised $58M on August 18, 2021

Investors: NS Investment, M Ventures, The Leukemia & Lymphoma Society, Solasta Ventures, Mirae Asset MAPS Global Investments Co., Ltd, Longwood Fund and Medical Excellence Capital, LLC

I

Immunitas Therapeutics raised $39M on November 22, 2019

Investors: Evotec